Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study

Phase 3

• Conditions: Basal Cell Carcinoma

• Registration Number: NCT05046262
• Lead Sponsor: Bispebjerg Hospital

Brief Summary

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation

Detailed Description

25 patients with primary low-risk basal cell carcinoma treated with calcium electroporation, if partial or no response after 3 months the treatment was repeated. Follow-up 3 and 12 months after last treatment.

Study Timeline

• Study Start: 2020-01-08
• Status Verified: 2021-09
• Study First Submitted: 2021-09-08
• Study First Submitted QC: 2021-09-08
• Last Update Submitted: 2021-09-08
• Study First Posted: 2021-09-16
• Last Update Posted: 2021-09-16
• Primary Completion: 2022-02-22
• Study Completion: 2022-02-22

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

Primary low risk basal cell carcinoma less than 3 cm in diameter

Exclusion Criteria

Immunosuppression or organ transplant recipients Pregnancy or breastfeeding Allergy to local anesthetics

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
complete response	3 months

Trial Locations

Locations (1)

Department of Dermatology, Bispebjerg Hospital; 🇩🇰 Copenhagen, Denmark